European (re)insurance stocks fall as coronavirus drug flops in early trial
European and Asia-Pacific (re)insurance stocks have fallen after an overnight report raised doubts over a potential coronavirus treatment and as the economic toll of the outbreak becomes clearer.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below